Action:
Scheduling of drug in Schedule V
Action 5186
General Information
| Action Summary |
As specified in § 54.1-3443 (E), the Board has acted to schedule one drug in the Virginia Drug Control Act “after the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule.” The name of the drug product scheduled is identical to the federal rule. |
| Chapters Affected |
Only affects this chapter.
|
| Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
2.2-4006(13)
|
| RIS Project |
Yes [005748] |
| New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
8480
|
Final
|
Stage complete. This regulation became effective on 02/06/2019. |
Contact Information
|
Name / Title:
|
Caroline Juran, RPh
/
Executive Director
|
|
Address:
|
9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
|
|
Email Address:
|
caroline.juran@dhp.virginia.gov
|
|
Phone:
|
(804)367-4456
FAX: (804)527-4472
TDD: ()-
|
This person is the primary contact for this chapter.
